Rochester General Hospital/Lipson Cancer and Blood Center — Rochester, New York

Rochester General Hospital/Lipson Cancer and Blood Center is a clinical research site located in Rochester, New York, United States 14621.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rochester General Hospital/Lipson Cancer and Blood Center has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, Iron Overload.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester General Hospital/Lipson Cancer and Blood Center?

Rochester General Hospital/Lipson Cancer and Blood Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester General Hospital/Lipson Cancer and Blood Center conducted?

Rochester General Hospital/Lipson Cancer and Blood Center has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome, Iron Overload.

Is Rochester General Hospital/Lipson Cancer and Blood Center accredited by Crixeo Health?

Rochester General Hospital/Lipson Cancer and Blood Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester General Hospital/Lipson Cancer and Blood Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.